As the BBC reports this morning, alongside a great introductory video about Pre-Exposure Prophulaxis (or PrEP), the National AIDS Trust (NAT) has won a High Court ruling that is set to over-turn the NHS position on funding the “game-changing” treatment. Some months ago, NHS England announced that it considered the provision of PrEP to be a
NHS England has approved an £18.7 million investment in a new drug for the treatment of hepatitis C. Around 500 patients with acute liver failure, and/or awaiting liver transplantation, are expected to benefit from the decision to fund Sofosbuvir. The hepatitis C virus causes inflammation of the liver, affecting its ability to function. Whilst many
